findmyKOL

Kyle Popovich, MD

Basic profile

Rush University Medical Center

ORCIDNPI
RegionChicago, IL · MidwestSpecialtyInfectious DiseaseFocusInfectious Disease
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPaymentsNone reportedNIH funding2010–2025Why? →

Kyle Popovich is an Infectious Disease physician affiliated with Rush University Medical Center. OpenAlex indexes 96 publications with 2,412 citations (h-index 26).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
96publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,412citations

Total citations across indexed works.

26h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4NIH grants · 2010–2025

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

600 S Paulina St
Suite 140
Chicago, IL 606123806

Telephone

312-942-5865

Provider last certified this registry record 28 Apr 2021.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    47.4%
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor16.7%
    Tivicay100%
    Part D<11 patients
    Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor10.5%
    Triumeq100%
    Part D<11 patients

    + 2 more classes in this area

  • Cardiovascular

    31.6%
    Statin19.3%
    Rosuvastatin Calcium100%
    Part D<11 patients
    Beta blocker12.3%
    Metoprolol Succinate100%
    Part D<11 patients
  • Genitourinary & hormones

    21.1%
    alpha-Adrenergic Blocker11.4%
    Tamsulosin Hcl100%
    Part D<11 patients
    Cholinergic Muscarinic Antagonist9.6%
    Solifenacin Succinate100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

4 NIH research awards on record, funded 20102025 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”